UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Hanmi slates US-based phase 1 trial for LAPSTriple Agonist: CEO
Hanmi Pharmaceutical is ramping up efforts to enter the global market with ...
by Marian Chu
|
2018-01-11 15:59
라인
AstraZeneca gets go-ahead for biologic asthma drug in Europe
AstraZeneca and its global research and development subsidiary MedImmune sa...
by Marian Chu
|
2018-01-11 10:48
라인
Eli Lilly withdraws testosterone replacement therapy from Korea
Eli Lilly and Company has taken its topical testosterone replacement therap...
by Marian Chu
|
2018-01-10 17:11
라인
AbbVie’s atopic dermatitis drug designated ‘breakthrough therapy’
AbbVie Korea said Wednesday that upadacitinib, its investigational therapy ...
by Marian Chu
|
2018-01-10 14:13
라인
Seoul retains ban on prime-time junk food ads
Korea will indefinitely uphold its policy that bars television ads of unhea...
by Marian Chu
|
2018-01-09 17:20
라인
First plastic tube oral cholera vaccine makes global debut, IVI says
The world’s first plastic tube presentation of oral cholera vaccine, Euvich...
by Marian Chu
|
2018-01-09 12:26
라인
Why doesn’t Korea advertise condoms?
Korea takes up the lion’s share in manufacturing condoms worldwide but rank...
by Marian Chu
|
2018-01-09 11:00
라인
Korean researchers develop new photodynamic therapy for breast cancer
New Korean research presents a new strategy for breast cancer treatment tha...
by Marian Chu
|
2018-01-08 19:13
라인
5 Korean pharmaceuticals jump into biobetter developing business
Big name Korean pharmaceuticals are shifting their focus to a new type of t...
by Marian Chu
|
2018-01-08 15:59
라인
Biogen’s spinal muscular atrophy treatment gains approval in Korea
Biogen Korea said Monday that it gained approval for its potential blockbus...
by Marian Chu
|
2018-01-08 14:27
라인
Takeda’s lung cancer drug designated orphan drug in Korea
Takeda Pharmaceuticals Korea said Monday the Ministry of Food and Drug Safe...
by Marian Chu
|
2018-01-08 11:19
라인
Should Korean schools supply free condoms?
The Health Education Forum, a civic group comprised of around 3,000 Korean ...
by Marian Chu
|
2018-01-05 17:06
라인
J&J faces charge for forcing distributors to pay kickbacks to medical staffs
A local distributor of Johnson & Johnson Medical Korea filed a complaint ag...
by Marian Chu
|
2018-01-05 15:45
라인
Statin therapy effective in only 28% of Korean high-cholesterol patients: study
A Korean study showed statin therapy, traditionally used to treat high chol...
by Marian Chu
|
2018-01-04 15:56
라인
B. Braun Korea sharply cuts catheter prices to improve access
The Korean branch of German medical device specialist B. Braun Korea said T...
by Marian Chu
|
2018-01-04 14:03
라인
Novartis’ breast cancer therapy wins FDA breakthrough designation
The U.S. Food and Drug Administration designated Novartis’ breast cancer dr...
by Marian Chu
|
2018-01-04 10:44
라인
Korean professor gets $800,000 from Merck for biomarker research
A professor at Konkuk University Medical Center will receive $800,000 in fu...
by Marian Chu
|
2018-01-03 10:49
라인
Korea has 1 doctor for 440 patients: report
The patient to doctor ratio in Korea is improving significantly, the Minist...
by Marian Chu
|
2018-01-02 17:19
라인
WHO to classify excessive video gaming as mental disorder
Too much video gaming may soon be classified as a mental, behavioral or neu...
by Marian Chu
|
2018-01-02 11:28
라인
Electric blankets increase risk of miscarriage: study
Electric blankets warm you in winter and save on your power bills. Are they...
by Marian Chu
|
2018-01-02 08:52
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top